Use of comprehensive genomic profiling for biomarker discovery for the management of non-small cell lung cancer brain metastases.
Abdulhaleem M, Hunting JC, Wang Y, Smith MR, Agostino RJ, Lycan T, Farris MK, Ververs J, Lo HW, Watabe K, Topaloglu U, Li W, Whitlow C, Su J, Wang G, Chan MD, Xing F, Ruiz J. Use of comprehensive genomic profiling for biomarker discovery for the management of non-small cell lung cancer brain metastases. Front Oncol. 2023; 13:1214126.